Clinical Weight Loss With GLP-1: What the First Consultation Looks Like

Clinical weight loss with GLP-1 medicines starts with a medical assessment, not a prescription pad. If you're thinking about semaglutide or tirzepatide, knowing what happens in the first visit can make the whole process less intimidating. Here's what to expect before, during, and after your first prescription.

Clinical weight loss versus cosmetic use

Clinical weight loss means treating a diagnosed condition, usually obesity or a weight-related problem such as high blood pressure, under medical supervision. Cosmetic use is different. Someone wants to lose a few kilos for appearance and skips the assessment entirely. The doctor's job in the clinical path is to confirm the diagnosis, check for risks, and decide whether the treatment fits.

The molecule matters less than the label. Semaglutide is sold in Brazil under different brand names with different approved uses. Ozempic is approved by Anvisa for type 2 diabetes. Wegovy, which contains a higher dose of semaglutide, is approved for chronic weight management. Using a drug for a purpose outside its approved indication is called off-label use. Brazilian doctors can prescribe off-label under their own professional responsibility and with informed consent, but it still requires a clinical justification.

Who can prescribe and who qualifies

Endocrinologists, obesity medicine specialists, and general practitioners who follow current protocols can all prescribe these medicines. Many patients are referred to a specialist when their history is complicated. Whatever the specialty, the prescriber should be a licensed physician registered with the CRM in their state. If you're unsure, you can check that registration on your state medical council's website. OzemBlog can also point you to other credentials worth confirming before you book.

For Wegovy, the approved criteria are based on body mass index. The label covers adults with a BMI of 30 or higher, or a BMI of 27 or higher who also have at least one weight-related condition, such as high blood pressure, dyslipidemia, or obstructive sleep apnea. Always confirm the wording in the current prescribing information, because labels get updated.

A type 2 diabetes diagnosis changes the pathway. The conversation usually starts with blood glucose control, and Ozempic is prescribed for that indication. Weight may still matter, but the treatment is then managed as diabetes care. In Brazil, a prescription must come from a licensed doctor, and pharmacies dispense these medicines against that prescription. Anvisa and the Federal Council of Medicine (CFM) set the rules.

What happens in the first consultation

The visit usually begins with your history. Your doctor will ask about past weight-loss attempts, current medications and supplements, eating patterns, sleep, and mood. Many clinics also screen for eating disorders or emotional eating, since those can change how the plan should be built.

Next comes the physical exam. Expect measurements of weight, height, BMI, waist circumference, and blood pressure. Waist size helps show where fat is stored, which matters for cardiovascular risk.

Lab work comes next. HbA1c is ordered when diabetes is suspected or needs monitoring. The usual panel also includes a lipid profile, kidney function, liver enzymes, and thyroid function. The Brazilian obesity and diabetes societies, SBEM and SBD, publish guidance that many clinics follow, though the exact panel varies.

The safety screen is the part people most often underestimate. Semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors seen in rodent studies. These medicines should not be used by people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2). Your doctor will also ask about pancreatitis, gallbladder disease, and whether you're pregnant, breastfeeding, or planning a pregnancy. Be direct, even when a question feels awkward. The label advises stopping before planned pregnancy, so timing matters.

Dose escalation and what the doctor adjusts

Doses start low and rise slowly, usually every four weeks. The goal is to reduce gastrointestinal side effects like nausea, diarrhea, and constipation. For Wegovy, the label schedule begins at 0.25 mg once weekly and steps up toward the maintenance dose of 2.4 mg. Ozempic starts at 0.25 mg weekly and then moves to 0.5 mg. Check the current prescribing information for each product, since the steps are part of the official label.

Some symptoms call for a quick call to the clinic. Persistent vomiting that stops you from keeping fluids down, or severe abdominal pain that could signal pancreatitis, needs prompt attention. Your doctor may pause or lower the dose in those cases.

At follow-up visits, your doctor reviews your weight, appetite, side effects, and labs. Then they decide whether to keep the dose, hold it, or move up. Dose changes are a clinical decision, not something you adjust alone. Skipping or doubling doses because the drug feels too strong or too weak can cause real problems.

How the drug works alongside diet, protein, and exercise

In plain terms, GLP-1 is a hormone your gut releases after a meal. Semaglutide and tirzepatide mimic its effects. They slow how quickly the stomach empties, which can help you feel full longer. They also act on appetite signals in the brain. And they stimulate insulin release mainly when blood glucose is high, which is one reason low blood sugar is less common with these drugs when used alone.

Not all weight lost is fat. Some lean mass usually goes too, which is why clinicians stress protein intake and resistance training. Keeping muscle supports strength and metabolism as weight comes down. A registered dietitian can set a protein target, which is often higher than the standard recommendation, and build an eating plan you can actually keep. For a general overview of treatment basics before your appointment, read the OzemBlog homepage at the OzemBlog homepage.

Trial numbers help set expectations, as long as you read them as averages. In STEP-1, adults on semaglutide 2.4 mg lost about 15 percent of their body weight over 68 weeks, compared with about 2 percent on placebo. In SURMOUNT-1, tirzepatide 15 mg was associated with an average loss of about 21 percent over 72 weeks, versus about 3 percent on placebo. Participants also received lifestyle support.

Access, cost, and realistic expectations in Brazil

The main access routes are private prescription with pharmacy purchase, health plan coverage where it exists, and limited options within the public system. Coverage depends on your specific plan and indication, so read your contract carefully. Prices change over time. The CMED list, published by the Brazilian government, sets maximum prices for medicines, so check the current list before you budget.

Results vary widely between people, and a plateau after several months does not automatically mean the treatment failed. Your doctor may review dose, activity, sleep, and other medications before deciding anything else. Also plan for what happens if you stop. Follow-up studies have reported weight regain after discontinuation, so your plan should cover long-term habits from the start, not after you stop.

Preparing for the appointment

Bring a written list of questions. Our printable question checklist is a good starting point, and you can adapt it to your situation. Strong questions usually cover:

• What timeline should I expect before I see meaningful changes?
• What is the plan if side effects show up, and who do I call?
• When are my lab follow-ups scheduled, and which tests will be repeated?
• What happens if my weight loss stalls for several weeks?

Bring a current medication list, including supplements and anything you take only occasionally. Add your past weight history too: when your weight changed, what you tried, and what happened afterward. This context helps your doctor separate a new problem from an old pattern.

Two weeks before the visit, track your weight, meals, and symptoms. A notebook or phone app works fine. Record meal times, portion sizes, hunger levels, and any nausea, constipation, or fatigue. Two weeks of notes give your doctor far better information than memory alone.

FAQ

Can I get Wegovy in Brazil without seeing a doctor?

No. Pharmacies dispense these medicines against a prescription from a licensed physician, and the first visit is where that prescription is decided.

Is Ozempic the same as Wegovy?

Both contain semaglutide, but the doses and approved uses differ. Ozempic is indicated for type 2 diabetes in Brazil, while Wegovy is indicated for chronic weight management in adults who meet the label criteria.

Will I get a prescription on the same day as my first consultation?

It depends. Your doctor may need your lab results or a complete safety screen first, so some patients receive the prescription at a second visit.

Does a family history of thyroid cancer rule out GLP-1 treatment?

A personal or family history of medullary thyroid carcinoma or MEN2 is a contraindication on the label. Tell your doctor about any family history of thyroid cancer, even if you're unsure of the type.

Sources

• Anvisa, Agência Nacional de Vigilância Sanitária
• Conselho Federal de Medicina (CFM)
• CMED, Câmara de Regulação do Mercado de Medicamentos
• Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
• Sociedade Brasileira de Diabetes (SBD)
• Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), New England Journal of Medicine
• Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1), New England Journal of Medicine
• PubMed, National Library of Medicine